I read few more times about patients and trials ,
Post# of 144900
I was just surprise with this statement , because when once I did a study for Hoffmann La Roche ,
They had few meetings with me before they even send IND to FDA , what type of patients I will need , and before they filed I had my list of patients I spoke with , who were great candidates for this study.
This is why I remembered it on the spot...
![Like This Post](/images/thumb-up.png)
![Dislike This Post](/images/thumb-down.png)